Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122484) titled 'Study on the Predictive Value of Cancer therapy-related cardiovascular toxicity Risk in Breast Cancer Patients' on April 14.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Second Affiliated Hospital of Dalian Medical University
Condition:
Breast Cancer
Intervention:
Cancer Therapy-Related Cardiac Dysfunction:None
Recruitment Status: Recruiting
Phase: 0
Date of First Enrollment: 2025-01-01
Target Sample Size: Cancer Therapy-Related Cardiac Dysfunction:50;None Cancer Therapy-Related Cardiac Dysfunction:50;
Countries of Recruitment:
China
To know more, visit https:/...